梅州处女膜修补 时间(梅州白带发黄异味) (今日更新中)

OCEANSIDE (KGTV) - Three women were injured Sunday evening in a shooting at an Oceanside shopping center, according to Oceanside Police.Police said three Hispanic women were in front of a clothing store in the 3700 block of Mission Boulevard, when three black men suddenly came up to them, shortly after 5 pm. Two of the three suspects shot at the three young women. All the victims suffered non-life-threatening gunshot wounds and went to the hospital. Waitress Angelica Camiro was on her break, treating her nephews to a cup of ice-cream from the shop next door. On their way back, she saw the commotion. "The only thing was, 'Save the kids!' because I don't know what was happening," Camiro said. She immediately ran back into the restaurant and told all the customers to get to the back of the store. Then they called Police. Witnesses said the suspects got away in a dark sedan. If anybody has any information, please contact the Oceanside Police. 995

OTAY MESA (CNS) - A pedestrian died Thursday after being struck by a hit- and-run motorist near Brown Field Municipal Airport, authorities reported.The 21-year-old woman was in a crosswalk in the 8200 block of Otay Mesa Road when a westbound silver Nissan Altima struck her about 9:15 a.m., according to San Diego police.The victim, whose name was withheld pending family notification, died at the scene.Following the fatal impact, the motorist continued driving and fled the area to the west, Officer Tony Martinez said.The vehicle is described as a four-door, silver-colored Nissan Altima. It was last seen traveling northbound on Heritage Rd. towards Chula Vista. 674

OCEANSIDE, Calif (KGTV) -- A pedestrian was struck and killed by a semi-truck on Interstate 5 near Mission Avenue early Thursday morning.According to California Highway Patrol, the pedestrian was standing in the middle of the southbound lanes around 2:30 a.m. when they were hit. Deputies say the victim was killed instantly.The semi-truck driver did stay at the scene.Deputies are investigating why the victim was in the middle of the freeway. 452

On Monday morning, Pfizer announced that so far in Phase 3 trials, its COVID-19 vaccine candidate has been 90% effective in promoting protection against the virus. And while the announcement has many Americans seeing the light at the end of the tunnel, the pandemic is still far from over.Pfizer's announcement on Monday is an encouraging sign, as it means that the company is on track to file for Emergency Use Authorization for the vaccine in the coming weeks. It also keeps the U.S. on a timeline to have at least one vaccine approved and available for distribution by the end of 2021.But Monday's announcement does not mean a vaccine is imminent. Pfizer is currently mass-manufacturing its vaccine candidate in the event it does receive Emergency Use Authorization from the FDA, and hopes to have 100 million doses of the vaccine ready to ship by year's end. But even if Pfizer is able to fulfill that ambitious order by Dec. 31, it would only be able to vaccinate about one-third of everyone in the county.Once the initial vaccine order has been completed, it will need to be rationed for those who need it most — likely health care workers, essential employees and people in high-risk populations. While it is unclear who exactly will be eligible to receive the vaccine first, the Department of Health and Human Services (HHS) says the early distribution of a COVID-19 vaccine will be "constrained tightly" and will be "highly targeted" to "achieve coverage in priority populations."Eventually, the U.S. hopes to grant emergency use authorization to several vaccine candidates — many of which are currently in production on orders from the U.S. government. HHS hopes that by the middle of next year, several vaccines will be approved and widely available. But at that point, officials will run into a second major hurdle — vaccine skepticism.Skepticism about vaccines has been on the rise in recent years, fueled in part by the spread of misinformation online. In particular, baseless conspiracies linking vaccines to autism have spread on social media, eroding public confidence in medicine. In addition, polarized politics in the U.S. have led to speculation that government leaders will approve an unsafe or ineffective vaccine for political purposes.Vaccines are only effective if enough members of the public become inoculated against a virus — if a virus has nowhere to spread, it will eventually die out. But Gallup polling released in October shows that just 50% of Americans say they would receive a COVID-19 vaccine if it had been approved by the FDA and available at no cost — far below the threshold for herd immunity, according to many health experts.The Gallup polling is consistent with AP polling from earlier this year that also only found 50% willingness to take a COVID-19 vaccine.All the while, the final push for a COVID-19 vaccine will be occurring during what members of the White House coronavirus task force warn will be the most concerning and deadly period of the pandemic. The virus is currently spreading in the U.S. faster than it has at any other point during the pandemic, just as Americans are moving social gatherings indoors where the virus is more likely to spread.To be clear, health officials' efforts to develop a safe and effective COVID-19 is a momentous and historic achievement — approving a vaccine for emergency use by the end of the year would shatter all previous records for vaccine development. But while there may be light at the end of the tunnel, it may take several months — or years — to reach the end of the pandemic. 3586

One student was killed in a shooting at Freeman High School near Spokane, Washington, Fire Chief Brian Schaeffer said at a news conference.Three other juveniles are in stable condition at a hospital.The suspect was detained, the Spokane County Sheriff's Office tweeted. 277

来源：资阳报